Hundreds enrolled in canadian HIV trials.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001761:Bleomycin / Q000008:administration & dosage; D002170:Canada; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000008:administration & dosage; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D019888:Nelfinavir; D011241:Prednisone / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D019438:Ritonavir / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000627:therapeutic use*; D014750:Vincristine / Q000008:administration & dosage; D015215:Zidovudine / Q000008:administration & dosage
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D013451:Sulfonic Acids; D001761:Bleomycin; D015215:Zidovudine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D019888:Nelfinavir; D019438:Ritonavir; D011241:Prednisone